InvestorsHub Logo
Followers 1
Posts 255
Boards Moderated 0
Alias Born 02/05/2001

Re: jcryan19 post# 52

Wednesday, 04/19/2006 11:46:03 AM

Wednesday, April 19, 2006 11:46:03 AM

Post# of 135
Thought you might enjoy the reply:

Dear Jim,

Thanks for your interest in eGene. Please see our response in blue.

Regards,

Varouj Amirkhanian

Executive VP / Director

Instrument Systems R&D

eGene, Inc.

17841 Fitch

Irvine, CA 92614

Ph: (949) 250-8686

Fax: (949) 250-8833

www.egeneinc.com



The hardest part of being a investor in your company is understanding the 100 machines you currently have out there and are they being actively used. It would also be helpful to understand the economy of what you're offering and do you see the jell packs as a good future revenue stream?
Yes, we have shipped more than 120 units worldwide. They are being used by our assigned distributors as demo units and more than 100 units have been installed at customer labs ranging in University Research labs, Pharmaceutical Companies, Food Industry, Law Enforcement, CDC, large Government Organizations and small businesses all involved in DNA/RNA type analysis/applications.


Here are some of the Users:



· Research Institutes:

§ Riken Genomic Sciences Center, National Institute of Health Sciences, National Institute of Technology and Evaluation, Research Institute for Natural Science, National Institute of Genetics, National Agricultural Research Center, Central Laboratories for Experimental Animals, National Institute for Basic Biology, National Institute of Livestock and Grassland Science (Japan);

§ International Vaccine Institute, Forest Research Institute, National Institute of Crop Science (Korea);

§ Academic Sinica, Agriculture Research Institute, Center for Disease Control (Taiwan);

§ Research Institute of Molecular Pathology (Austria) ;

§ Australian Genome Research Facility (Australia);



· Universities:

§ Tokyo University, Osaka University, Kyoto University, Teikyo University, Hirosaki University, Nagoya University (Japan);

§ Lausanne University (Switzerland),

§ Padua University (Italy);

§ Univ.Calif Irvine; Ohio State University (USA);

§ Univ.Innsbruck (Austria)



· Hospital & Medical Schools:

§ Univ.Mass. Medical Center, Boston Children Hospital (USA),

§ Saitam Cancer Center, Jichi Medical School (Japan),

§ National Taiwan University Hospital, Taiwan Mackay Memorial Hospital, Taiwan Cathay General Hospital, National Young Ming Medical School (Taiwan)



· Pharmaceutical/ Biotech Industry:

§ Glaxosmithkline, Johnson & Johnson, GeneVault, Texas BioGene, Transgenomic, Inc. Invitrogene, Inc. (USA),

§ Hitachi Science Systems, Ltd, Dainippon Pharmaceutical Co., LTD. Nippon Paper Group, Takii Seed Company (Japan)

§ Johnson & Johnson (Belgium & US)



I hope you don't mind a novice question, can your equipment be used to test for Mad Cow disease and would it be economically feasible?

Yes, our technology is CE (Capillary Electrophoresis, please check our web site for more: www.egeneinc.com) with fluorescence detection. And by altering the gel chemistry for the disposable cartridges one can use it for Mad Cow disease detection as well.

If a specialty medical clinic was created, could a single test be used to cover several different diseases, like Alzheimer, Multiple scleroses ect, would this be a computer program looking for different markers?
Yes, We would use different Gel-Cartridges with specific Markers to cover the range of tests.

Is your biggest problem now the political ramifications of letting so many lab tech's go, when your product removes most of their usefulness?
No, the Instrument does not remove people, it improves productivity and efficiency of the testing labs by automating the high-throughput DNA/RNA screening process, which translates to lowers cost per sample. The automated analyzer allows the high skilled technicians (mostly Ph.D.s) to spend their valuable time in more productive manner, to do better planning of their experiments/tests.


Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.